Johnson & Johnson’s Johnson Coronavirus Disease (COVD-19) vaccine.
Johnson and Johnson by Reuters
The White House is considering enhancing intellectual property protection on Covid-19 vaccines.
The move would allow other countries to replicate existing vaccines. The United States has so far approved three shots: one developed by American company Pfizer and German-based Bioentech, another by US company Moderna, and another by American companies Johnson & Johnson.
U.S. And concerns have been raised about the issues of other rich countries entitled to disproportionate amounts of global vaccine supply, while other countries struggle to inoculate their people.
House Speaker Nancy Pelosi has backed the move to the White House. Developing countries have also urged the WTO to make intellectual property available.
According to the Centers for Disease Control and Prevention, about 19% of American adults and about 15% of the total U.S. population are fully vaccinated.
Subscribe to CNBC on YouTube.